Literature DB >> 22802645

Requirement for the histone deacetylase Hdac3 for the inflammatory gene expression program in macrophages.

Xuefen Chen1, Iros Barozzi, Alberto Termanini, Elena Prosperini, Antonio Recchiuti, Jesmond Dalli, Flore Mietton, Gianluca Matteoli, Scott Hiebert, Gioacchino Natoli.   

Abstract

Histone deacetylases (HDACs) regulate inflammatory gene expression, as indicated by the potent antiinflammatory activity of pan-HDAC inhibitors. However, the specific contribution of each of the 11 HDAC proteins to the inflammatory gene expression program is unknown. Using an integrated genomic approach, we found that Hdac3-deficient macrophages were unable to activate almost half of the inflammatory gene expression program when stimulated with LPS. A large part of the activation defect was attributable to loss of basal and LPS-inducible expression of IFN-β, which maintains Stat1 protein levels in unstimulated cells and acts in an autocrine/paracrine manner after stimulation to promote a secondary wave of Stat1-dependent gene expression. Loss of Hdac3-mediated repression of nuclear receptors led to hyperacetylation of thousands of genomic sites and associated gene derepression. The up-regulation of the constitutively expressed prostaglandin endoperoxide synthase, Ptgs1 (Cox-1), a nuclear receptor target, had a causative role in the phenotype because its chemical inhibition reverted, albeit partially, the Ifn-β activation defect. These data indicate a central role for Hdac3 in inflammation and may have relevance for the use of selective Hdac inhibitors as antiinflammatory agents.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22802645      PMCID: PMC3479529          DOI: 10.1073/pnas.1121131109

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  58 in total

1.  Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IkappaB kinase.

Authors:  A Rossi; P Kapahi; G Natoli; T Takahashi; Y Chen; M Karin; M G Santoro
Journal:  Nature       Date:  2000-01-06       Impact factor: 49.962

2.  The S. cerevisiae SET3 complex includes two histone deacetylases, Hos2 and Hst1, and is a meiotic-specific repressor of the sporulation gene program.

Authors:  W W Pijnappel; D Schaft; A Roguev; A Shevchenko; H Tekotte; M Wilm; G Rigaut; B Séraphin; R Aasland; A F Stewart
Journal:  Genes Dev       Date:  2001-11-15       Impact factor: 11.361

3.  Metabolomics-lipidomics of eicosanoids and docosanoids generated by phagocytes.

Authors:  Rong Yang; Nan Chiang; Sungwhan F Oh; Charles N Serhan
Journal:  Curr Protoc Immunol       Date:  2011-11

4.  Histone deacetylase 3 is an epigenomic brake in macrophage alternative activation.

Authors:  Shannon E Mullican; Christine A Gaddis; Theresa Alenghat; Meera G Nair; Paul R Giacomin; Logan J Everett; Dan Feng; David J Steger; Jonathan Schug; David Artis; Mitchell A Lazar
Journal:  Genes Dev       Date:  2011-12-01       Impact factor: 11.361

5.  15-deoxy-delta 12,14-prostaglandin J2 inhibits multiple steps in the NF-kappa B signaling pathway.

Authors:  D S Straus; G Pascual; M Li; J S Welch; M Ricote; C H Hsiang; L L Sengchanthalangsy; G Ghosh; C K Glass
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-25       Impact factor: 11.205

6.  The antitumor histone deacetylase inhibitor suberoylanilide hydroxamic acid exhibits antiinflammatory properties via suppression of cytokines.

Authors:  Flavio Leoni; Andrea Zaliani; Giorgio Bertolini; Giulia Porro; Paolo Pagani; Pietro Pozzi; Giancarlo Donà; Gianluca Fossati; Silvano Sozzani; Tania Azam; Philip Bufler; Giamila Fantuzzi; Igor Goncharov; Soo-Hyun Kim; Benjamin J Pomerantz; Leonid L Reznikov; Britta Siegmund; Charles A Dinarello; Paolo Mascagni
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-26       Impact factor: 11.205

Review 7.  Histone deacetylase inhibitors: new drugs for the treatment of inflammatory diseases?

Authors:  Frédéric Blanchard; Céline Chipoy
Journal:  Drug Discov Today       Date:  2005-02-01       Impact factor: 7.851

8.  The histone deacetylase-3 complex contains nuclear receptor corepressors.

Authors:  Y D Wen; V Perissi; L M Staszewski; W M Yang; A Krones; C K Glass; M G Rosenfeld; E Seto
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-20       Impact factor: 11.205

9.  IRF3 mediates a TLR3/TLR4-specific antiviral gene program.

Authors:  Sean Doyle; Sagar Vaidya; Ryan O'Connell; Hajir Dadgostar; Paul Dempsey; Ting Wu; Govinda Rao; Ren Sun; Margaret Haberland; Robert Modlin; Genhong Cheng
Journal:  Immunity       Date:  2002-09       Impact factor: 31.745

10.  Fish the ChIPs: a pipeline for automated genomic annotation of ChIP-Seq data.

Authors:  Iros Barozzi; Alberto Termanini; Saverio Minucci; Gioacchino Natoli
Journal:  Biol Direct       Date:  2011-10-06       Impact factor: 4.540

View more
  155 in total

1.  YAP/TAZ deficiency reprograms macrophage phenotype and improves infarct healing and cardiac function after myocardial infarction.

Authors:  Masum M Mia; Dasan Mary Cibi; Siti Aishah Binte Abdul Ghani; Weihua Song; Nicole Tee; Sujoy Ghosh; Junhao Mao; Eric N Olson; Manvendra K Singh
Journal:  PLoS Biol       Date:  2020-12-02       Impact factor: 8.029

2.  FOXP3+ regulatory T cell development and function require histone/protein deacetylase 3.

Authors:  Liqing Wang; Yujie Liu; Rongxiang Han; Ulf H Beier; Tricia R Bhatti; Tatiana Akimova; Mark I Greene; Scott W Hiebert; Wayne W Hancock
Journal:  J Clin Invest       Date:  2015-02-02       Impact factor: 14.808

3.  Loss of the co-repressor GPS2 sensitizes macrophage activation upon metabolic stress induced by obesity and type 2 diabetes.

Authors:  Rongrong Fan; Amine Toubal; Saioa Goñi; Karima Drareni; Zhiqiang Huang; Fawaz Alzaid; Raphaelle Ballaire; Patricia Ancel; Ning Liang; Anastasios Damdimopoulos; Isabelle Hainault; Antoine Soprani; Judith Aron-Wisnewsky; Fabienne Foufelle; Toby Lawrence; Jean-Francois Gautier; Nicolas Venteclef; Eckardt Treuter
Journal:  Nat Med       Date:  2016-06-06       Impact factor: 53.440

Review 4.  The ascent of acetylation in the epigenetics of rheumatoid arthritis.

Authors:  Aleksander M Grabiec; Kris A Reedquist
Journal:  Nat Rev Rheumatol       Date:  2013-02-26       Impact factor: 20.543

5.  Histone deacetylase 3 preferentially binds and collaborates with the transcription factor RUNX1 to repress AML1-ETO-dependent transcription in t(8;21) AML.

Authors:  Chun Guo; Jian Li; Nickolas Steinauer; Madeline Wong; Brent Wu; Alexandria Dickson; Markus Kalkum; Jinsong Zhang
Journal:  J Biol Chem       Date:  2020-02-18       Impact factor: 5.157

6.  Epigenomics and the microbiota.

Authors:  Theresa Alenghat
Journal:  Toxicol Pathol       Date:  2014-10-20       Impact factor: 1.902

Review 7.  Epigenetic control of myeloid cell differentiation, identity and function.

Authors:  Damiana Álvarez-Errico; Roser Vento-Tormo; Michael Sieweke; Esteban Ballestar
Journal:  Nat Rev Immunol       Date:  2015-01       Impact factor: 53.106

8.  Isoform-selective inhibitor of histone deacetylase 3 (HDAC3) limits pancreatic islet infiltration and protects female nonobese diabetic mice from diabetes.

Authors:  Ercument Dirice; Raymond W S Ng; Rachael Martinez; Jiang Hu; Florence F Wagner; Edward B Holson; Bridget K Wagner; Rohit N Kulkarni
Journal:  J Biol Chem       Date:  2017-08-31       Impact factor: 5.157

9.  Tet2 is required to resolve inflammation by recruiting Hdac2 to specifically repress IL-6.

Authors:  Qian Zhang; Kai Zhao; Qicong Shen; Yanmei Han; Yan Gu; Xia Li; Dezhi Zhao; Yiqi Liu; Chunmei Wang; Xiang Zhang; Xiaoping Su; Juan Liu; Wei Ge; Ross L Levine; Nan Li; Xuetao Cao
Journal:  Nature       Date:  2015-08-19       Impact factor: 49.962

Review 10.  Metabolic reprogramming by class I and II histone deacetylases.

Authors:  Maria M Mihaylova; Reuben J Shaw
Journal:  Trends Endocrinol Metab       Date:  2012-10-09       Impact factor: 12.015

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.